OCT 07, 2017 1:49 PM PDT

Defective Viral Genomes Help Infections Linger

WRITTEN BY: Kara Marker

Cells that are infected with a virus sacrifice themselves, dying before the virus has a chance to use the cell’s own machinery to replicate and spread to other cells. This is why viral infections like respiratory syncytial virus (RSV), measles, parainfluenza, and Ebola are acute, not long-lasting. But when viruses find a way to linger in their host’s cells without being killed by the immune system, the infection transforms from acute to chronic, causing multiple complications.

Making insights into how virus-infected cells can survive the onslaught of an immune response, researchers have found that cells enriched with defective viral genomes (in green) had strategies to persist, unlike cells with more full-length viral genomes (in orange/yellow). Credit: University of Pennsylvania

In a new Nature Communications study, researchers from the University of Pennsylvania identify a mechanism responsible for viruses overstaying their welcome in the human body. The culprit? Defective viral genomes.

As a virus invades the body and begins to mass-produce itself by manipulating the replication machinery of the body’s own cells, the virus can make mistakes while replicating the genome, leading to defective viral genomes (DVGs) present in some cells. Senior author of the new study, Carolina B. López, has researched DVGs for a long time. Interestingly, DVGs simultaneously instigate an immune response to the virus and stimulate a molecular pathway that prevents infected cells from self destruction.

“DVGs promote persistent infections in tissue culture," López explained. "How do you reconcile that with the fact that they're also very immunostimulatory? How can they help clear virus at the same time as they promote persistence? Our work helps explain this apparent paradox."

In her newest study, López and her team of researchers observed DVGs in cells, picking apart the cells with full-length genomes, the cells with DVGs, and the cells with some of each. Then, researchers infected healthy cells with either RSV or the Sendai virus, looking at the difference when viruses were DVG-deficient versus DVG-rich.

In their study, researchers used Respiratory Syncytial Virus (pictured) and the Sendai virus, also known as murine parainfluenza virus type 1, is an RNA virus not pathogenic to humans. It was first isolated in the 1950s in Japan and has been used ever since as a tool in the research lab.

Researchers observed cells infected with DVG-rich virus surviving significantly longer than those with DVG-deficient viruses, confirming that DVGs were directly involved in the survival of virally-infected cells.

How exactly are DVG-rich virally-infected cells avoiding apoptosis? A gene expression analysis revealed that “pro-survival genes” are very active in DVG-rich cells.

“These data show that our cells are wired to survive if they are engaged in an antiviral response, explaining the paradoxical functions of DVGs,” Lopez explained. “It seems that in order to persist, the virus is taking advantage of these host pathways that are there to promote the survival of cells working to eliminate the virus."

Now that Lopez knows how viruses are able to linger in the body, she hopes to find a way to prevent this from happening. "I want to see if there's a way we can harness this pathway to minimize and avoid the persistence of these viruses.”

Sources: Current Gene Therapy, University of Pennsylvania

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 16, 2019
Health & Medicine
JUL 16, 2019
Rare Bone Marrow Manifestation in Sarcoidosis
Sarcoidosis is an inflammatory disease with the hallmark diagnostic feature being non-caseating granulomas--clumps of immune cells including macr...
OCT 14, 2019
Immunology
OCT 14, 2019
This is How Your Immune System Responds to Ebola Vaccination
Vaccines to prevent Ebola are still in their infancy, with experimental-only versions being used only in the most dire of instances. In a new study, scient...
OCT 17, 2019
Health & Medicine
OCT 17, 2019
STDs Still on the Rise in U.S.
Last week, the Centers for Disease Control and Prevention (CDC) released its annual Sexually Transmitted Disease Surveillance Report, the details of which...
NOV 12, 2019
Immunology
NOV 12, 2019
Allergy Shots May Work for Kids with Pollen Food Allergy Syndrome
It’s not common for young children to develop pollen food allergy syndrome (PFAS), but for those that do, there’s not too much parents can do o...
JAN 08, 2020
Cell & Molecular Biology
JAN 08, 2020
In a First, Scientists Generate Early Human Immune Cells in the Lab
Now we know more about the early stages of the human immune system....
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
Potential Cure for Coronavirus Found in Thailand
Doctors in Thailand have successfully treated people affected by the coronavirus via a new drug cocktail made out of antiviral, flu and HIV medication. Alt...
Loading Comments...